Quantinno Capital Management LP Grows Stock Position in Amedisys, Inc. (NASDAQ:AMED)

Quantinno Capital Management LP raised its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 60.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 40,457 shares of the health services provider's stock after purchasing an additional 15,238 shares during the period. Quantinno Capital Management LP owned 0.12% of Amedisys worth $3,905,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. KBC Group NV purchased a new position in Amedisys during the 3rd quarter worth $63,000. Innealta Capital LLC purchased a new stake in shares of Amedisys during the second quarter worth about $64,000. Signaturefd LLC grew its stake in shares of Amedisys by 88.2% during the second quarter. Signaturefd LLC now owns 1,131 shares of the health services provider's stock worth $104,000 after acquiring an additional 530 shares during the last quarter. CWM LLC increased its holdings in shares of Amedisys by 14.5% during the third quarter. CWM LLC now owns 2,190 shares of the health services provider's stock valued at $211,000 after acquiring an additional 277 shares in the last quarter. Finally, Crossmark Global Holdings Inc. purchased a new position in shares of Amedisys in the 3rd quarter valued at approximately $243,000. Hedge funds and other institutional investors own 94.36% of the company's stock.

Amedisys Stock Performance

NASDAQ:AMED traded down $0.45 during trading hours on Monday, hitting $85.58. 392,238 shares of the company were exchanged, compared to its average volume of 371,026. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. Amedisys, Inc. has a 52-week low of $84.06 and a 52-week high of $98.95. The stock has a market capitalization of $2.80 billion, a price-to-earnings ratio of 34.14, a PEG ratio of 1.85 and a beta of 0.73. The company's 50 day moving average price is $93.71 and its 200-day moving average price is $95.30.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.19). The company had revenue of $587.67 million for the quarter, compared to analysts' expectations of $586.75 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. Amedisys's quarterly revenue was up 5.7% compared to the same quarter last year. During the same period last year, the firm earned $0.98 earnings per share. As a group, research analysts forecast that Amedisys, Inc. will post 4.45 earnings per share for the current year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.